Jennifer Fundora, MD

Johns Hopkins Outpatient Center offers a comprehensive range of imaging and radiology services, state-of-the-art facilities and a talented faculty of experts in radiology who use their specialized knowledge to deliver the best patient care possible.

Dr. Kartikeya Makker is the medical director of the Johns Hopkins Bayview Medical Center neonatal intensive care unit (NICU) and a neonatologist at Johns Hopkins Children’s Center in Baltimore, Maryland. He diagnoses and treats premature babies and newborns with high-risk or complex health conditions. Dr. Makker graduated from the Smt. NHL Municipal Medical College. He then completed a residency in pediatrics at the Maimonides Medical Center, and later a fellowship in neonatal-perinatal medicine at the Medical College of Wisconsin Affiliated Hospitals.

Matthew Ippolito, M.D., Ph.D. is an Associate Professor of Medicine and the Director of Clinical Epidemiology for the Southern and Central Africa International Centers of Excellence for Malaria Research (ICEMR). He received his A.B. from Dartmouth College and his M.D. from the Geisel School of Medicine at Dartmouth. He completed his Internal Medicine Internship and Residency at the University of California, San Francisco, and fellowships in Infectious Diseases and Clinical Pharmacology at the Johns Hopkins University School of Medicine where he received his Ph.D. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. He also served in the Peace Corps in Ghana, West Africa. Dr. Ippolito specializes in global health and tropical infectious diseases with a research focus on malaria in sub-Saharan Africa. His NIH-supported research program explores the clinical pharmacology of antimalarial drugs and the genetic epidemiology of drug resistance. In his role as Director of Clinical Epidemiology for the Southern and Central Africa ICEMR, Dr. Ippolito designs and oversees clinical, translational, and epidemiological studies of malaria. Dr. Ippolito also serves as a Phase I and II clinical trialist for the LONGEVITY consortium, established to develop and deploy long-acting nanoformulations of essential anti-infective drugs. He is also a co-developer of a computer vision-based machine learning platform for malaria diagnostic and research applications, and serves on the editorial board of Frontiers in Malaria.